Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palonosetron Buccal Film vs IV for Prevention of CINV
NCT05199818Phase 3Unknown
- Sponsor
- Lipin Pharmaceutical
- Start
- Mar 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Lipin Pharmaceutical. Status: unknown.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT05199818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05199818.